Structural Heart

This structural heart channel includings content related to heart valve repair and replacement, left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs and PFOs.

The U.S. Food and Drug Administration expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects.
News | Heart Valve Technology | March 07, 2018

The U.S. Food and Drug Administration expanded the approval of a...

Videos | Heart Valve Technology | March 02, 2018

Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the...

Contrast-Free Cardiac MRI May Better Assess Need for Mitral Valve Surgery
News | Magnetic Resonance Imaging (MRI) | February 27, 2018

February 27, 2018 – A new study published in the Journal of the American College of Cardiology confirms non-invasive...

Boston Scientific Projects 2019 Launch for Lotus Edge Aortic Valve System
News | Heart Valve Technology | February 23, 2018

February 23, 2018 — Boston Scientific announced In November 2017 a delay to timelines for commercialization of the...

Gate Bioprosthesis Used in Canada's First Transcatheter Valve Replacement for Tricuspid Regurgitation
News | Heart Valve Technology | February 22, 2018

February 22, 2018 — NaviGate Cardiac Structures Inc. (NCSI)announced that on Feb. 2, 2018, its catheter-guided Gate...

AtriCure Launches AtriClip FLEX•V Device in the United States
Technology | Left Atrial Appendage (LAA) Occluders | February 22, 2018

February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V...

Sentinel Cerebral Protection System Reaches 50-Center Adoption Milestone in U.S.
News | Embolic Protection Devices | February 19, 2018

February 19, 2018 — Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June...

Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve has been approved with CE mark for use in Europe.
Feature | Heart Valve Technology | February 15, 2018

February 15, 2018 — Edwards Lifesciences Corp. has received European CE mark clearance for its self-expanding...

The Boston Scientific Rhythmia Mapping System produces higher-density voltage maps without increasing overall procedure time.

The Boston Scientific Rhythmia Mapping System produces higher-density voltage maps without increasing overall procedure time. It was featured in the top article posted in January on new technologies to treat atrial fibrillation.

Feature | February 05, 2018

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

ACC 2018 highlights and trends.  #acc.18, #ACC, #ACC2018
Feature | ACC | January 31, 2018

The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating....

Boston Scientific Enters Investment and Acquisition Option Agreement With Millipede
News | Heart Valve Technology | January 24, 2018

January 24, 2018 — Boston Scientific Corp. announced it has closed an investment and entered into an acquisition...

J&J Announces U.S. IDE Study to Evaluate Potential of New Device to Reduce Stroke Risk in Afib
News | Left Atrial Appendage (LAA) Occluders | January 18, 2018

January 18, 2018 – Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc., a...

Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology | January 11, 2018

January 11, 2018 — The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its...

Videos | Cath Lab | January 04, 2018

Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif...

Videos | Heart Valve Technology | January 04, 2018

Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how...

Overlay Init